title: Sequencing firms eye pathology labs as next big market opportunity.
authors.forename: Laura
authors.initials: L
authors.lastname: DeFrancesco
authors.forename: Nidhi
authors.initials: N
authors.lastname: Subbaraman
mesh_terms: D015415:Biomarkers; D001709:Biotechnology / Q000191:economics*; D002648:Child; D019295:Computational Biology / Q000379:methods*; D006801:Humans; D007449:Investments / Q000191:economics*; D007753:Laboratories / Q000191:economics*; D008297:Male; D009154:Mutation; D017422:Sequence Analysis, DNA / Q000379:methods*; D012984:Software; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000235:genetics
chemical_list: D015415:Biomarkers; D051636:X-Linked Inhibitor of Apoptosis Protein